Article info
PDFCorrespondence
Tocilizumab in patients with adult-onset Still’s disease refractory to glucocorticoid treatment
- Correspondence to Professor Young Ho Lee, Division of Rheumatology, Korea University Medical Center, Seoul 02841, South Korea; lyhcgh{at}korea.ac.kr
Citation
Tocilizumab in patients with adult-onset Still’s disease refractory to glucocorticoid treatment
Publication history
- Received October 23, 2018
- Accepted October 26, 2018
- First published November 2, 2018.
Online issue publication
May 12, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.